(76 days)
No
The document explicitly states that the device uses the same principles of operation, electronic circuitry, detector technology, design concepts, functionality, calculations, algorithms, and response as the predicate device. The primary changes are a touch screen interface and an expanded MCA for spectral identification, neither of which inherently involve AI/ML. There is no mention of AI, DNN, or ML in the document.
No.
The device is a dose calibrator used to measure radioactive materials for diagnostic, therapeutic, or in vitro laboratory tests, but it does not directly deliver therapy itself.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device measures "radiopharmaceuticals and radioactive materials...for diagnostic, therapeutic, or in vitro laboratory tests."
No
The device description clearly states it is a "dose calibrator" and mentions "detector technology," indicating it includes hardware components for measuring radioactive materials. While it has a touch screen interface and enhanced software features, it is not solely software.
Based on the provided text, this device is an IVD (In Vitro Diagnostic).
Here's why:
- The "Intended Use / Indications for Use" section explicitly states that the device is intended for use in "in vitro laboratory tests".
- The "Device Description" section also mentions the device is used in "laboratory tests" and "in vitro" applications.
- Specifically, the well counter component is described as being designed for "measurement of low activity radioactive sources or solutions in vitro laboratory test applications."
While the device has broader applications (diagnostic imaging, therapy, research), the inclusion of "in vitro laboratory tests" as an intended use makes it fall under the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The CRC 55t series, which includes the standard 55tR dose calibrator, reduced pressure chamber (CRC 55tPET) and well counter (CRC55tW), is intended to be used by qualified nuclear medicine technologists, nuclear medicine physicians, and radiopharmacists to measure a wide range of radiopharmaceuticals and radioactive materials, including high energy beta and gamma emitters for diagnostic, therapeutic, or in vitro laboratory tests. It is also designed for use by trained medical physicists to measure the output of most radioactive brachytherapy sources, including LDR, HDR, and IVBT sources. All brachytherapy sources must be measured in the appropriate source holder. The well counter is designed for measurement of low activity radioactive sources or solutions in vitro laboratory test applications. This device is also used in numerous research applications for measurement of radioactive materials.
Product codes
KPT, JAQ
Device Description
Capintec's CRC 55t series dose calibrators are designed for measurement of radioactive materials used in nuclear medicine, therapy, laboratory tests, and research applications. The unit is intended for use by trained nuclear medicine technologists, nuclear medicine physicians, radiopharmacists, or medical physicists for diagnostic, in vitro, and therapeutic applications.
The CRC 55t series uses the same principles of operation, same basic electronic circuitry, and same detector technology as the predicated device, CRC 25 series. The basic detection, measurement process, design concepts, functionality, calculations, algorithms, and response remain the same as the predicate device. There are no differences in intended use or effectiveness. The 55t replaces the traditional keypad interface with a larger color touch screen display. The CRC 55t provides enhanced user interface features associated with newer touch screen technology. In addition, the CRC 55t provides an expanded MCA for isotope identification. The predicate device contains 6 fixed channels which provides only preliminary information. The CRC 55t includes a 256 channel MCA which permits spectral identification.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained nuclear medicine technologists, nuclear medicine physicians, radiopharmacists, or medical physicists
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The CRC 55t family of dose calibrators have been tested and approved to the following EMC and electrical safety standards for laboratory equipment:
- IEC 61010-1 Safety requirements for electrical equipment for measurement, . control, and laboratory use-Part 1 General Requirements
- IEC 61010-2-101 Safety requirements for electrical equipment for measurement. . control, and laboratory use-Part 2 Particular Requirement for In Vitro Diagnostic Equipment
- IEC 60601-1-2 Medical electrical equipment Part 1-2: General requirements for . basic safety and essential performance -Collateral standard: Electromagnetic compatibility - Requirements and tests
- UL 61010A-1 Electrical Equipment for Laboratory Use; Part 1: General . Requirements
- CAN/CSA-C22.2 No. 61010-1-04 Standard for Safety Electrical Equipment for . Measurement, Control, and Laboratory Use; Part 1: General Requirements
- CAN/CSA-C22.2 No. 61010-2-101-04 Safety Requirements for Electrical . Equipment for Measurement, Control, and Laboratory Use; Part 2-101: Particular Requirements for In Vitro Diagnostics (IVD) Medical Equipment
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1360 Radionuclide dose calibrator.
(a)
Identification. A radionuclide dose calibrator is a radiation detection device intended to assay radionuclides before their administration to patients.(b)
Classification. Class II.
0
AUG - 9 2010
Image /page/0/Picture/1 description: The image shows the logo for CAPINTEC, INC. The logo features the letters "CII" stacked on top of each other inside of a black box. Below the box is the text "CAPINTEC, INC." in a simple, sans-serif font. The logo is black and white.
July 9, 2010
RE: Summary of Safety and Effectiveness Information for the Capintec CRC 55t series.
Capintec's CRC 55t series dose calibrators are designed for measurement of radioactive materials used in nuclear medicine, therapy, laboratory tests, and research applications. The unit is intended for use by trained nuclear medicine technologists, nuclear medicine physicians, radiopharmacists, or medical physicists for diagnostic, in vitro, and therapeutic applications.
The CRC 55t series uses the same principles of operation, same basic electronic circuitry, and same detector technology as the predicated device, CRC 25 series. The basic detection, measurement process, design concepts, functionality, calculations, algorithms, and response remain the same as the predicate device. There are no differences in intended use or effectiveness. The 55t replaces the traditional keypad interface with a larger color touch screen display. The CRC 55t provides enhanced user interface features associated with newer touch screen technology. In addition, the CRC 55t provides an expanded MCA for isotope identification. The predicate device contains 6 fixed channels which provides only preliminary information. The CRC 55t includes a 256 channel MCA which permits spectral identification.
The predicate devices, Capintec dose calibrator lines, upon which the CRC 55t is based, have a long history of over 30 years of safe, reliable, and effective use in the field. The addition of a larger color touch screen interface enhances safety and effectiveness by providing improved visibility, easier alphanumeric data input, better graphic displays. more preset functions, and improved reports. The enhanced MCA provides improved isotope identification. The CRC 55t family of dose calibrators have been tested and approved to the following EMC and electrical safety standards for laboratory equipment:
- IEC 61010-1 Safety requirements for electrical equipment for measurement, . control, and laboratory use-Part 1 General Requirements
- IEC 61010-2-101 Safety requirements for electrical equipment for measurement. . control, and laboratory use-Part 2 Particular Requirement for In Vitro Diagnostic Equipment
- IEC 60601-1-2 Medical electrical equipment Part 1-2: General requirements for . basic safety and essential performance -Collateral standard: Electromagnetic compatibility - Requirements and tests
- UL 61010A-1 Electrical Equipment for Laboratory Use; Part 1: General . Requirements
- CAN/CSA-C22.2 No. 61010-1-04 Standard for Safety Electrical Equipment for . Measurement, Control, and Laboratory Use; Part 1: General Requirements
- CAN/CSA-C22.2 No. 61010-2-101-04 Safety Requirements for Electrical . Equipment for Measurement, Control, and Laboratory Use; Part 2-101: Particular Requirements for In Vitro Diagnostics (IVD) Medical Equipment
620 Alpha Drive • Pittsburgh, PA 15238 U.S.A. • (412) 963-1988 FAX (412) 963-0610
1
Image /page/1/Picture/0 description: The image shows a logo for the Department of Health. The logo features a stylized abstract symbol consisting of three curved lines stacked on top of each other. To the left of the symbol, the words "DEPARTMENT OF HEALTH" are arranged vertically in a curved manner.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Ms. Mary Anne Dell Vice President, Manufacturing Capintec, Inc. 620 Alpha Drive PITTSBURG PA 15238
AUG - 9 2010
Re: K101452
Trade/Device Name: CRC 55t Series Regulation Number: 21 CFR 892.1360 Regulation Name: Radionuclide dose calibrator Regulatory Class: II Product Code: KPT and JAQ Dated: July.27, 2010 Received: July 28, 2010
Dear Ms. Dell:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
2
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 200). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (01) 796-5450: Also, please note the regulation entitled, "Misbranding by reference to parent ket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll the from the (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Sincerely yours,
Donald J. St.Pierre Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
3
Appendix # 5
Indications for Use Form
Page _________________________________________________________________________________________________________________________________________________________________________ of of ________________________________________________________________________________________________________________________________________________________________________ ﺍﻟﻤﺴﺎﺣﺔ ﺍﻟﻤﺴﺘﻘﻠﺔ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘ
510(k) Number K 101452
Device Name: CRC 55t series
Indications For Use: The CRC 55t series, which includes the standard 55tR dose calibrator, reduced pressure chamber (CRC 55tPET) and well counter (CRC55tW), is intended to be used by qualified nuclear medicine technologists, nuclear medicine physicians, and radiopharmacists to measure a wide range of radiopharmaceuticals and radioactive materials, including high energy beta and gamma emitters for diagnostic, therapeutic, or in vitro laboratory tests. It is also designed for use by trained medical physicists to measure the output of most radioactive brachytherapy sources, including LDR, HDR, and IVBT sources. All brachytherapy sources must be measured in the appropriate source holder. The well counter is designed for measurement of low activity radioactive sources or solutions in vitro laboratory test applications. This device is also used in numerous research applications for measurement of radioactive materials.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Affice of Device Evaluation (QBE) OTT/ / OR Over-The-Counter Use Prescription Use I (Per 21 CFR 801.109) (Optional Format 1-2-96) Divisio Division of Rac logical Devic
Division of Imaging
Office of In Vitro Diagnostic Device Evaluation and Safety
K161452
510K
AUG - 9 2010